Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2025-12-24 @ 3:52 PM
NCT ID:
NCT06978192
Eligibility Criteria:
Inclusion Criteria:
* Patients with adverse reactions that are not effective in conventional drug treatment and cannot tolerate drugs
* The pain is located in the corresponding innervated are
* The pain affects the patient's daily life or work
* Diagnostic nerve block is effective and pain limited
* Recurrent herpes zoster pain
* Patients with shingle-related pain aged 40-85 years
Exclusion Criteria:
* Infection at the puncture site, systemic infection that may spread, and malignant tumors near the puncture
* There are contraindications in minimally invasive interventional therapy such as coagulation function and platelet dysfunction
* Allergies to local anesthetics and inhalants
* Heart, lung, liver, kidney and other important organ failure, can not tolerate surgery
* Severe endocrine system diseases or long-term use of hormone or immunosuppressive therapy
* Patients with cardiac pacemakers, pregnant or lactating women
* Patients with cognitive dysfunction or poor coordination
* Patients who have been treated with electrical stimulation or PRF
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT06978192
Study Brief:
Protocol Section:
NCT06978192